UNIVERSITY HOSPITAL OSTRAVA has floated a tender for The active substances of KEYTRUDA 25 mg / ml inf., 50mg in 1 lag.inf. with a content of Pembrolizumab 25 mg in 1ml, or 50mg in 1lag.. The project location is Czech Republic and the tender is closing on 02 Dec 2019. The tender notice number is VZ0081546, while the TOT Ref Number is 38126527. Bidders can have further information about the Tender and can request the complete Tender document by Registering on the site.

Expired Tender

Procurement Summary

Country : Czech Republic

Summary : The active substances of KEYTRUDA 25 mg / ml inf., 50mg in 1 lag.inf. with a content of Pembrolizumab 25 mg in 1ml, or 50mg in 1lag.

Deadline : 02 Dec 2019

Other Information

Notice Type : Tender

TOT Ref.No.: 38126527

Document Ref. No. : VZ0081546

Competition : ICB

Financier : Self Financed

Purchaser Ownership : -

Tender Value : Refer Document

Purchaser's Detail

Purchaser : UNIVERSITY HOSPITAL OSTRAVA
17. listopadu 1790/5, 708 52 Ostrava - Poruba, Czech Republic
Phone: +420 597 371 1111
Czech Republic
Email :fno@fno.cz
URL :www.fno.cz

Tender Details

Tender invited for The active substances of KEYTRUDA 25 mg / ml inf., 50mg in 1 lag.inf. with a content of Pembrolizumab 25 mg in 1ml, or 50mg in 1lag.

Brief Description : The Subject Of Fulfillment Are Continuous And Repeated Deliveries Of The Medicinal Product Keytruda With Content Substance Pembrolizumab From Atc Group L01xc18. Individual Deliveries Will Be Realized On The Basis Of Partial Orders Of The Client - Pharmacy Fn Ostrava.

Registration Order Number : Z2016-003695

System Number : P19V00165991

Internal Number : DNS-01/16-VZ-70/19

Dead Line : 02/12/2019

Contact Person

Name and surname: Petra Plevova
Job position: officer, dept. commercial-law
Telephone: 420 597 373 080
Mobile phone:
Fax: +420 596 916 056
Email: petra.plevova@fno.cz

Documents

 Tender Notice